Announced Fri, 8 May · 17:55 IST

Niva Bupa Health Insurance Company Limited has informed the Exchange regarding Resignation of Ms. Penelope Ruth Dudley as Non- Executive Director of the company w.e.f. May 08, 2026.

Multiple Ind Directors ResignedDirector Flagged GovernanceManagement Changes View source PDF

NIVABUPA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+2.8%1-day move
₹81.29
prior close
₹84.40
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+3.8+4.9+3.8+3.7+2.8+1.5-1.4-1.6-1.6+0.4+3.3+1.7+8.4
Up moveDown movePending
AI summary

Niva Bupa's Board meeting on May 8, 2026 approved multiple changes. Two Non-Executive Directors - Ms. Penelope Ruth Dudley and Mr. Carlos Antonio Jaureguizar Ruiz-Jarabo - resigned citing insufficient time due to other professional commitments. In replacement, the Board appointed Mr. Christopher Patrick Carroll (CEO of Bupa Global, India & UK) and Ms. Siobhan Djihan Moynihan (CFO of Bupa Global, India & UK) as Additional Non-Executive Directors effective May 15, 2026, subject to shareholder approval within 3 months. Additionally, Mr. Ankur Kharbanda was elevated from Executive Director and CBO to Executive Director and Deputy CEO. The Board also approved granting 12,251,268 ESOPs to eligible employees at an exercise price of ₹72.45 per option.

Likely market impact

The resignation of two non-executive directors in one meeting may raise governance concerns, though their replacements with senior Bupa executives suggest continuity. The ESOP grant of 12.25 million options is significant and aligns employee interests with shareholders.